Amlodipine Besylate Tablet
Product Images NDC 70518-4464
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 70518-4464). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 01 (14b2acb6 Ce0c 4f70 9d0a B6726c945ac2 02)
Figure 02 (14b2acb6 Ce0c 4f70 9d0a B6726c945ac2 03)
This is a table with data comparing the effectiveness of Amlodipine versus Placebo in patients based on different demographics and health conditions. The table includes information on age groups, gender distribution, baseline blood pressure, presence of vessel disease, stenosis in vessels, and PCI-stent strata. The Hazard Ratio with a 95% Confidence Interval is also provided for reference. The mean sitting baseline Systolic Blood Pressure (SBP) is stated as 129 mmHg.*
Remedy_label (Remedy Label)
This is a description of Amlodipine Besylate 10 mg tablets, packaged by RemedyRepack Inc. The tablets should be protected from light and stored at temperatures between 15-30°C. The medication is manufactured by Unichem in Ghaziabad, India. It is important to keep this medication out of the reach of children.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.